FDA Sidelines Chief Spokesperson As It Grapples With Fallout From COVID-19 Plasma Authorization

Emily Miller, who joined FDA a few days before its controversial roll out of emergency use authorization for convalescent plasma, remains at the agency. Situation shows importance of sticking to science-based decisions, former FDA officials say.